Flore's formulation intelligence is grounded in real-world data from our own cohorts and in published, peer-reviewed research. What follows is what we've observed and the studies behind the rationale. This is real-world evidence — observational, uncontrolled, and largely self-reported. No statement here is a disease claim.

Systems

Gastrointestinal The Regular One

Strains: Bifidobacterium animalis ssp. lactis + Bifidobacterium longum

Observed in our paired cohort — early interval (<6 months)
  • Pooled GI symptom resolution: 47.3% (334/706)
  • IBS: 64.7% (44/68)
  • Stomach pain: 61.8% (21/34)
  • Frequent diarrhea: 61.1% (33/54)
  • Leaky gut: 54.5% (42/77)
  • GERD: 54.2% (13/24)

Resolution compounds over timeThe figures above reflect the earliest follow-up window. GI symptom resolution is not a one-time snapshot — in the paired cohort (n=651) it compounds across successive intervals as the formulation is iterated against repeat sequencing, climbing from the ~47% pooled rate at the first interval to over 88% by the end of the course (~20 months).

Follow-up interval Pooled GI resolution
<6 months (early) ~47.3%
By end of course (~20 months) >88%

Read as a single curve: resolution starts near 47% in the first months and climbs past 88% by the end of the course (~20 months) in the GI cohort — the same start-to-landing trajectory, measured at two points along it, not two competing numbers.

Rationale (mechanistic, not measured)Bifidobacterium fermentation of fiber to short-chain fatty acids supports motility and mucosal-barrier integrity.

Study: Martoni CJ, et al. Impact of a probiotic product on bowel habits in functional constipation. J Dig Dis. 2019;20(9):478–487. PMID 31271261. pubmed.ncbi.nlm.nih.gov/31271261

Mood / Neurological The Bright One

Strains: Bifidobacterium animalis ssp. lactis + Lactiplantibacillus plantarum

Observed in our paired cohort
  • Pooled neuro resolution: 49.3% (135/274)
  • Depression: 65.0% (26/40)
  • Brain fog: 48.5% (47/97)
  • Fatigue: 48.5% (66/136)
  • Anxiety: 45.2% (47/104)

Rationale (mechanistic, not measured)Gut–brain-axis modulation of tryptophan metabolism and vagal signaling.

Study: Hidalgo-Cantabrana C, et al. Lactiplantibacillus plantarum HEAL9 improves cognition in moderately stressed subjects. Nutrients. 2023;15(15):3466. PMID 37571403. pubmed.ncbi.nlm.nih.gov/37571403

Joint / Musculoskeletal The Mighty One

Strains: Bifidobacterium animalis ssp. lactis + Bifidobacterium bifidum

Observed in our paired cohort
  • Pooled joint resolution: 55.3% (42/76)
  • Arthritis: 61.9% (13/21)
  • Fibromyalgia: 61.1% (11/18)
  • Joint pain: 48.6% (18/37)

Rationale (mechanistic, not measured)Anti-inflammatory rationale matching the observed arthritis/fibromyalgia signal.

Immune The Strong One

Strains: Lactobacillus acidophilus + Bifidobacterium longum

Observed in our paired cohort
  • Chronic inflammation: 64.3% (45/70)
  • Immune deficiency: 60.0% (9/15) †small sample; interpret with caution

Rationale (mechanistic, not measured)GALT priming and secretory-IgA support.

Study: Leyer GJ, et al. Probiotic effects on cold and influenza-like symptom incidence in children. Pediatrics. 2009;124(2):e172–179. PMID 19651563. pubmed.ncbi.nlm.nih.gov/19651563

Skin The Clear One

Strains: Lactobacillus salivarius + Bifidobacterium animalis ssp. lactis

Observed in our paired cohort
  • Pooled skin resolution: 36.5% (42/115)
  • Psoriasis: 61.1% (11/18)
  • Dermatitis: 50.0% (7/14)
  • Eczema: 34.2% (13/38)
  • Acne: 24.4% (11/45)

Metabolic The Lean One

Strains: Bifidobacterium animalis ssp. lactis + Streptococcus thermophilus

No within-subject resolution data in the cohort — mechanistic / structure-function only.

Study: Stenman LK, et al. Probiotic with or without fiber controls body fat mass in overweight adults. EBioMedicine. 2016;13:190–200. PMID 27810310. pubmed.ncbi.nlm.nih.gov/27810310

Focus & Calm The Calm One

Strains: Bifidobacterium animalis ssp. lactis + Limosilactobacillus reuteri

Mechanism / structure-function only (preclinical gut–brain rationale; autism-spectrum cohort noted).

Study: Billeci L, et al. Effects of probiotics on electroencephalography in preschoolers with autism. Autism. 2023;27(3):814–827. PMID 35362336. pubmed.ncbi.nlm.nih.gov/35362336

Women's The Radiant One

Strains: Lactobacillus gasseri + Lactobacillus fermentum

Supports vaginal pH; no symptom-resolution data.

Study: Tomusiak A, et al. Efficacy and safety of a vaginal probiotic product containing L. fermentum + L. gasseri. Drug Des Devel Ther. 2015;9:5345–5354. PMID 26451088. pubmed.ncbi.nlm.nih.gov/26451088

Boosters — Tolerability

These are complaint / tolerability rates, not efficacy. Overall baseline complaint rate: 4.87% (n=18,383).

Booster FLORE code Complaint rate Target
Clear Skin (botanical) FLORE-B021 4.0% Skin
Digest Ease FLORE-0015 4.3% GI motility
Metabolic Fire FLORE-0016 4.5% Metabolic
Anti-Inflammatory (botanical) FLORE-B031 5.1% Systemic
Defense Plus FLORE-0017 5.5% Immune
Joint Ease FLORE-0018 5.7% Joint
Gut Seal FLORE-0019 5.9% Barrier
Mood Lift FLORE-0020 6.0% Mood
Skin Glow FLORE-0021 6.2% Skin
Stress Shield FLORE-0022 6.3% Stress
Focus Fuel FLORE-0023 6.8% Cognitive
Flora Balance FLORE-0024 9.8% Vaginal pH

Methodology

Figures are drawn from a paired real-world cohort (n=651; 1,379 symptom-instances) tracked across ~6.6-month median intervals and followed longitudinally out to 20 months, a tolerability cohort (n=18,383), and a sequencing cohort (n=14,704). Analyses used McNemar's test with Benjamini–Hochberg FDR correction. This is real-world evidence, not a controlled trial.

Peer-Reviewed Publication

Published in mSystems · American Society for Microbiology · 2024

Phan J, Calvo DC, Nair D, Jain S, Montagne T, Dietsche S, Blanchard K, Treadwell S, Adams J, Krajmalnik-Brown R. Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder. mSystems. 2024;9(5):e00503-24. PMID 38661344. doi.org/10.1128/msystems.00503-24

Conducted in collaboration with Arizona State University. A pilot open-label study (not a randomized controlled trial) — we say so plainly.

Foundational References

  • Hill C, et al. ISAPP consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514.
  • Sanders ME, et al. Probiotics and prebiotics in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2019;16(10):605–616.

References

  1. Martoni CJ, et al. Impact of a probiotic product on bowel habits in functional constipation. J Dig Dis. 2019;20(9):478–487. PMID 31271261. pubmed.ncbi.nlm.nih.gov/31271261
  2. Hidalgo-Cantabrana C, et al. Lactiplantibacillus plantarum HEAL9 improves cognition in moderately stressed subjects. Nutrients. 2023;15(15):3466. PMID 37571403. pubmed.ncbi.nlm.nih.gov/37571403
  3. Leyer GJ, et al. Probiotic effects on cold and influenza-like symptom incidence in children. Pediatrics. 2009;124(2):e172–179. PMID 19651563. pubmed.ncbi.nlm.nih.gov/19651563
  4. Stenman LK, et al. Probiotic with or without fiber controls body fat mass in overweight adults. EBioMedicine. 2016;13:190–200. PMID 27810310. pubmed.ncbi.nlm.nih.gov/27810310
  5. Billeci L, et al. Effects of probiotics on electroencephalography in preschoolers with autism. Autism. 2023;27(3):814–827. PMID 35362336. pubmed.ncbi.nlm.nih.gov/35362336
  6. Tomusiak A, et al. Efficacy and safety of a vaginal probiotic product containing L. fermentum + L. gasseri. Drug Des Devel Ther. 2015;9:5345–5354. PMID 26451088. pubmed.ncbi.nlm.nih.gov/26451088
  7. Hill C, et al. ISAPP consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514.
  8. Sanders ME, et al. Probiotics and prebiotics in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2019;16(10):605–616.

Press & Media

Press & media — for product samples, founder interviews, or clinical data briefings, contact support@flore.com

These statements have not been evaluated by the Food and Drug Administration. Flore products are not intended to diagnose, treat, cure, or prevent any disease.